After receiving concerns regarding the quality of the oral medication, the Pharmacy and Poisons Board (PPB), which is part of the Ministry of Health, has recalled the Tamedol oral solution (Paracetamol oral solution, 120mg/5m1, 60 mls).
In a statement released on Tuesday, PPB claimed that the medicine, produced by Biopharma LTD, had fallen short of the standards set forth for market authorization.
Therefore, the board warned that all pharmacies, medical facilities, healthcare workers, and members of the public should take immediate steps to stop the drug’s distribution and use.
PPB also raised a red flag about the sale of Visipaque (Iodixanol) 320 mg/mL vials in response to customer complaints about quality issues and possible bad reactions.
Visipaque (Iodixanol) 320 mg/mL batches 15950809, 15944839, 15950792, and 15906117 produced by GE Healthcare Ireland, Cork, Ireland, are the ones that are affected.
Visipaque (Iodixanol) 320 mg/mL is the alternative product, and it is made by GE Healthcare (Shanghai) Co., Ltd. in China under batch numbers 5389618, 15429745, 15444386, 15661498, 15904073, 15751274, 16017833, 16044911, 16085815, 16100415, 16107210, and 16177061.
In order to prevent future harm, PPB asked healthcare facilities that had batches of the implicated items to immediately quarantine them and contact the board’s offices.
They urged the public to be watchful and report any suspected cases of substandard medications or adverse drug reactions to the nearest healthcare facility, adding that they are committed to ensuring that the pharmaceutical items given to Kenyans are of standard quality.
